Key Laboratory of the Ministry of Education for Coastal and Wetland Ecosystems, School of Life Sciences, Xiamen University, Xiamen 361005, China.
Key Laboratory of the Ministry of Education for Coastal and Wetland Ecosystems, School of Life Sciences, Xiamen University, Xiamen 361005, China.
Biomed Pharmacother. 2020 Aug;128:110314. doi: 10.1016/j.biopha.2020.110314. Epub 2020 May 30.
With the rapid increase in the population of obese individuals, obesity has become a global problem. Many kinds of chronic metabolic diseases easily caused by obesity have received increasing attention from researchers. People are also striving to find various safe and effective treatment methods as well as anti-obesity medicines. Pancreatic lipase (PL) inhibitors have received substantial attention from researchers in recent years, and PL inhibitors from natural products have attracted much attention due to their structural diversity, low toxicity and wide range of sources. They have been used in the intestinal tract, blood, and the central nervous system with no side effects, and these advantages could lead to a new generation of diet pills or health care products with great development potential. This article is mainly aimed at discussing the research of obesity drug treatment with PL inhibitors and offers a brief review of related properties and the use of PL inhibitors in the field of weight loss.
随着肥胖人群的快速增加,肥胖已成为全球性问题。肥胖易引发多种慢性代谢性疾病,受到研究人员的日益关注。人们也在努力寻找各种安全有效的治疗方法和减肥药。近年来,胰脂肪酶(PL)抑制剂受到研究人员的广泛关注,天然产物来源的 PL 抑制剂由于结构多样性、低毒性和广泛的来源而受到关注。它们在肠道、血液和中枢神经系统中使用无副作用,这些优点可能导致新一代具有巨大发展潜力的减肥药或保健品。本文主要讨论了 PL 抑制剂治疗肥胖症药物的研究,并简要综述了相关性质和 PL 抑制剂在减肥领域的应用。